Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Qin Ryan"'
Autor:
Ana Szarfman, Jonathan G. Levine, Joseph M. Tonning, Frank Weichold, John C. Bloom, Janice M. Soreth, Mark Geanacopoulos, Lawrence Callahan, Matthew Spotnitz, Qin Ryan, Meg Pease-Fye, John S. Brownstein, W. Ed Hammond, Christian Reich, Russ B. Altman
Publikováno v:
Communications Medicine, Vol 2, Iss 1, Pp 1-7 (2022)
Szarfman et al. discuss the importance of efficient, easy access to large quantities of health data to improve medical care and further medical research. They outline the issues currently experienced accessing and exchanging data in the USA and provi
Externí odkaz:
https://doaj.org/article/23c8b972d7474f6e83a83ac54a0ac7c2
Autor:
Hui-Lee Wong, Rongmei Zhang, Bradley Lufkin, Yuhui Feng, An-Chi Lo, Manzi Ngaiza, Michael Wernecke, Qin Ryan, Amarilys Vega, Thomas E. MaCurdy, Jeffrey A. Kelman, David J. Graham
Publikováno v:
Drugs & Therapy Perspectives. 39:29-39
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b9ec21cfce8bd4120f389da1d2f346e9
https://doi.org/10.1007/s40267-022-00969-9
https://doi.org/10.1007/s40267-022-00969-9
Autor:
Jeffrey A. Kelman, Bradley Lufkin, Hui-Lee Wong, Thomas E. MaCurdy, Rima Izem, David J. Graham, An-Chi Lo, Amarilys Vega, Qin Ryan, Rongmei Zhang, Yuhui Feng, Michael Wernecke, Michael Alexander
Publikováno v:
Pharmacoepidemiology and Drug Safety. 30:626-635
PURPOSE Erythropoiesis-stimulating agents (ESAs), indicated for treating some patients with chemotherapy-induced anemia (CIA), may increase the risk of tumor progression and mortality. FDA required a Risk Evaluation and Mitigation Strategy (REMS) to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e3a107391de14bb0b9f15eb092cb5993
https://doi.org/10.1002/pds.5202
https://doi.org/10.1002/pds.5202
Autor:
Amarilys, Vega, Rongmei, Zhang, Hui-Lee, Wong, Michael, Wernecke, Michael, Alexander, Yuhui, Feng, An-Chi, Lo, Bradley, Lufkin, Qin, Ryan, Rima, Izem, Thomas E, MaCurdy, Jeffrey A, Kelman, David J, Graham
Publikováno v:
Pharmacoepidemiology and drug safetyREFERENCES. 30(5)
Erythropoiesis-stimulating agents (ESAs), indicated for treating some patients with chemotherapy-induced anemia (CIA), may increase the risk of tumor progression and mortality. FDA required a Risk Evaluation and Mitigation Strategy (REMS) to mitigate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::b7bc1d75e5a016c7dfae0c41501b3749
https://pubmed.ncbi.nlm.nih.gov/33534188
https://pubmed.ncbi.nlm.nih.gov/33534188
Autor:
Steven Kozlowski, Joo-Yeon Lee, Michael Wernecke, Cunlin Wang, Aliza Thompson, Robert C. Kane, Kimberly A. Smith, Yoganand Chillarige, Yute Wu, Jeffrey A. Kelman, Thomas E. MaCurdy, Zhiwei Zhang, Mark Levenson, Qin Ryan, Yuqin Wei, Chris Worrall, David J. Graham, Carmen Dekmezian
Publikováno v:
JAMA internal medicine. 176(12)
In 2011, the US Centers for MedicareMedicaid Services (CMS) changed its reimbursement policy for hemodialysis to a bundled comprehensive payment system that included the cost of erythrocyte-stimulating agents (ESAs). Also in 2011, the US Food and Dru
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7ae4f3070c4e6452fcba796f380ad66d
https://pubmed.ncbi.nlm.nih.gov/27775766
https://pubmed.ncbi.nlm.nih.gov/27775766
Publikováno v:
Viral Immunology. 5:201-211
To investigate the mechanism by which Friend leukemia virus (FV) causes immunosuppression, the ability of peritoneal macrophages to mediate antigen-specific T-cell activation following FV infection was examined. Decreased IL-2 production was observed
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c6c3b3528e1a2b04859ffd86b03d64dc
https://doi.org/10.1089/vim.1992.5.201
https://doi.org/10.1089/vim.1992.5.201
Autor:
Chia-Wen Ko, Martin H. Cohen, Robert Justice, Rajeshwari Sridhara, Qin Ryan, Amna Ibrahim, John R. Johnson, Richard Pazdur
Publikováno v:
The oncologist. 13(10)
Learning Objectives After completing this course, the reader should be able to: Describe the clinical trial that led to the approval of lapatinib in combination with capecitabine for the treatment of previously treated patients with HER-2–overexpre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5ab57cd4365c960028288f8d272f0438
https://pubmed.ncbi.nlm.nih.gov/18849320
https://pubmed.ncbi.nlm.nih.gov/18849320
Autor:
Cunlin Wang, Monica Houstoun, Qin Ryan, Chris Worrall, Katrina Mott, Diqiong Xie, Susan Limb, Ting-Chang Sheu, Michael Wernecke, David J. Graham, Thomas E. MaCurdy, Mark Levenson, Jeffrey A. Kelman, Robert C. Kane, Marsha E. Reichman, Sarah Wong
Publikováno v:
JAMA. 314:2062
All intravenous (IV) iron products are associated with anaphylaxis, but the comparative safety of each product has not been well established.To compare the risk of anaphylaxis among marketed IV iron products.Retrospective new user cohort study of IV
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6820cb9d6e40f9fa93c8bc5ede4287eb
https://doi.org/10.1001/jama.2015.15572
https://doi.org/10.1001/jama.2015.15572
Autor:
Eun Joo, Chung, Sunmin, Lee, Edward A, Sausville, Qin, Ryan, Judith E, Karp, Ivana, Gojo, William G, Telford, Min-Jung, Lee, Hye Sik, Kong, Jane B, Trepel
Publikováno v:
Annals of clinical and laboratory science. 35(4)
Histone deacetylase (HDAC) inhibitors are a promising new class of anticancer drug. The aim of this study was to develop a versatile and sensitive technique for the pharmacodynamic (PD) assessment of HDAC inhibitor activity as monotherapy and in comb
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::898f21bfcb9611aed524c4b6a10c90ef
https://pubmed.ncbi.nlm.nih.gov/16254255
https://pubmed.ncbi.nlm.nih.gov/16254255
Autor:
Cunlin Wang, Kane, Robert, Levenson, Mark, Kelman, Jeffrey, Wernecke, Michael, Joo-Yeon Lee, Kozlowski, Steven, Dekmezian, Carmen, Zhiwei Zhang, Thompson, Aliza, Smith, Kimberly, Yu-te Wu, Yuqin Wei, Chillarige, Yoganand, Qin Ryan, Worrall, Chris, MaCurdy, Thomas E., Graham, David J., Wang, Cunlin, Lee, Joo-Yeon
Publikováno v:
JAMA Internal Medicine; Dec2016, Vol. 176 Issue 12, p1818-1825, 8p